Mometasonfuroaat

Momecutan 1 mg/g mast

mastCroatiaMarketedAuthorised 16 Dec 2021

In other countries

The same active substances on other registers, the same brand first.

Bemrist Breezhaler 125 microgram/127,5 microgram inhalatiepoeder in harde capsulesNetherlands · Inhalatiepoeder in harde capsule · Novartis Europharm LimitedSame substance
Bemrist Breezhaler 125 microgram/260 microgram inhalatiepoeder in harde capsulesNetherlands · Inhalatiepoeder in harde capsule · Novartis Europharm LimitedSame substance
Bemrist Breezhaler 125 microgram/62,5 microgram inhalatiepoeder in harde capsulesNetherlands · Inhalatiepoeder in harde capsule · Novartis Europharm LimitedSame substance

Packs

Pack	Code	Status
10 g masti u tubi, u kutiji	HR-H-333625312-01	nije stavljeno u promet
15 g masti u tubi, u kutiji	HR-H-333625312-02	nije stavljeno u promet
20 g masti u tubi, u kutiji	HR-H-333625312-03	nije stavljeno u promet
25 g masti u tubi, u kutiji	HR-H-333625312-04

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Mometasonfuroaat

Momecutan 1 mg/g mast

mastCroatiaMarketedAuthorised 16 Dec 2021

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
10 g masti u tubi, u kutiji	HR-H-333625312-01	nije stavljeno u promet
15 g masti u tubi, u kutiji	HR-H-333625312-02	nije stavljeno u promet
20 g masti u tubi, u kutiji	HR-H-333625312-03	nije stavljeno u promet
25 g masti u tubi, u kutiji	HR-H-333625312-04

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH NN 67/2017 · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Mometasonfuroaat
Dosage form: mast
Register: Croatia (HALMED)
Status: Marketed
Status in the register: stavljeno u promet; nema nestašice
Authorised: 16 Dec 2021
Registration: HR-H-333625312
Marketing authorisation holder: Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska
Manufacturer: mibe GmbH Arzneimittel, Brehna, Njemačka
ATC code: D07AC13
Group: Dermatologicals
Procedure: National, MRP or DCP
Supply: na recept; u ljekarni

Elocom 1 mg/g otopina za kožuMometasonfuroaat · otopina za kožuCroatia

Momanose 50 mikrograma po potisku sprej za nos, suspenzijaMometasonfuroaat · sprej za nos, suspenzijaCroatia

Momecutan 1 mg/g kremaMometasonfuroaat · kremaCroatia

Momecutan 1 mg/g otopina za kožuMometasonfuroaat · otopina za kožuCroatia

Mometazonfuroat Cipla 50 mikrograma po potisku sprej za nos, suspenzijaMometasonfuroaat · sprej za nos, suspenzijaCroatia

Nasonex 50 mikrograma sprej za nos, suspenzijaMometasonfuroaat · sprej za nos, suspenzijaCroatia